LEQEMBI

Infusion Therapy

LEQEMBI infusion therapy is FDA-approved to treat patients with Alzheimer’s and may slow disease progression in patients in the early stages of Alzheimer’s. LEQEMBI infusion therapy is available at Optimum Care Infusion Center.

About LEQEMBI® Injection Therapy

LEQEMBI infusion therapy (lecanemab-irmb) is a biologic medication administered via IV (through the vein). The Food and Drug Administration approved LEQEMBI infusion therapy for patients in the early stages of Alzheimer’s. In a clinical study of patients with early Alzheimer’s disease, LEQEMBI was shown to reduce the amount of beta-amyloid plaque in the brain, a key marker for Alzheimer’s.

Beta-amyloid proteins collect and form plaques between neurons of the brain. The plaques affect brain and memory function. While LEQEMBI infusion therapy does not improve symptoms of Alzheimer’s, it can slow disease progression and prolong mental functioning.

LEQEMBI® Infusion Therapy for Alzheimer’s

LEQEMBI infusion therapy is the second in a class of new medications developed to slow disease progression and cognitive decline of patients with Alzheimer’s disease. Memory, including the ability to remember important dates, events, and conversations, and thinking and judgment skills may be maintained longer for patients receiving LEQEMBI infusion therapy.

In a phase 3 clinical trial of 1,795 participants, LEQEMBI infusion therapy patients’ clinical decline slowed by 27% after receiving treatment for 18 months.

LEQEMBI® Cost

The out-of-pocket LEQEMBI cost will vary depending on your insurance coverage. If you have Medicare Part B or Medicaid, some of the LEQEMBI cost may be covered. If you have questions about your coverage, contact your insurance provider.

Many patients with commercial insurance qualify for the LEQEMBI Copay Assistance Program which can help cover the LEQEMBI cost. For more information on LEQEMBI cost and financial resources, you may visit https://www.eisaipatientsupport.com/patient/leqembi/.

No patient should go without necessary treatment due to financial limitations. If you have questions about LEQEMBI cost or financial assistance opportunities, contact a member of our Optimum Care team.

What to Expect During LEQEMBI® Infusion Therapy

If a provider prescribes LEQEMBI infusion therapy, patients will receive a LEQEMBI infusion every 2 weeks throughout treatment. The length of treatment may be determined by the referring provider, with each infusion lasting approximately 1 hour.

LEQEMBI infusion patients require an MRI before their first treatment to evaluate for pre-existing amyloid-related imaging abnormalities (ARIA) and again after their 5th, 7th, and 14th infusions. ARIAs may develop in rare cases while receiving LEQEMBI infusion therapy. Most occurrences are asymptomatic and resolve on their own.

LEQEMBI Side Effects

While uncommon, some patients may experience LEQEMBI side effects, including mild infusion reactions (fever and flu-like symptoms, nausea, vomiting, hypotension, hypertension, and oxygen desaturation). Premedications, including antihistamines, acetaminophen, NSAIDs, or corticosteroids may be used to prevent symptoms of infusion reactions.

If you have concerns about LEQEMBI side effects, contact your referring provider.

LEQEMBI Infusion Therapy at Optimum Care

Your comfort during LEQEMBI infusion therapy at FlexCare is our priority. Our LEQEMBI patients enjoy private infusion suites, walk-up parking, and complimentary entertainment and snacks during each infusion. Plus, Optimum Care’s convenient location makes it easier to schedule your appointments.

Getting Started With LEQEMBI® Infusion Therapy

If you are interested in receiving LEQEMBI infusion therapy treatment at Optimum Care Infusion Center, talk to your doctor about sending us a referral.

If you have any questions, you can also contact Optimum Care directly. We look forward to helping you soon.

Providers – ready to learn more?

Request a visit from an Optimum Care representative, and a member of our team will come to your office to discuss our services.